PDC*line Pharma raised €18M in a Series B round in Dec 2021. The company is based in Liege, Belgium. Investors in the round: Alpha Holdings, Brain Asset Management, Hansongneotech Co. and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €18M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
